Table of Contents
Gene Therapy’s breakthrough in the field of Otolaryngology!
Otolaryngology encompasses the treatment of many diverse conditions, including: dizziness, hearing loss, problems of the larynx and sinus, difficulties swallowing, tumors of the auditory nerve, and voice production etc.
Gene Therapy: Role in Otolaryngology
Gene therapy has a checkered past and with this tumult serving as both a backdrop and a caution, gene therapy investigators in the 21st century agree that the field is enjoying a renaissance and that it has started showing promise in several fields of medicine, and has emerged as an embryonic field with enormous potential in the field of ear, nose and throat disorders.
Hearing loss and vestibular dysfunction (which causes imbalance disorders) are disabling conditions with high and increasing prevalence worldwide. It is estimated that one out of every five people in the U.S. over the age of 12 have hearing loss. There are currently no pharmacological treatments available. However with the help of gene therapy researchers have been successful in inducing formation of new inner ear sensory hair cells and the restoration of hearing and balance function.
Gene Therapy: The Market Scenario
A growing number of Big Pharma companies are partnering in drug development with innovation-rich biotech firms like between Novartis and GenVec are driving the new gene therapy research in the field of Otolaryngology. Currently GenVec is working in partnership with Novartis to discover and develop novel treatments for hearing loss and balance disorders. CGF166 is the lead compound being developed under the terms of this agreement and is believed to improve hearing that may be revealed as improved speech recognition, and the ability to benefit from a hearing aid and avoid the need for a cochlear implant. This has led to an increase in the global market opportunities for gene therapy with more companies focusing in this field.
DelveInsight’s Gene Therapy Reports
DelveInsight’s Gene Therapy Reports cover the entire gene therapy market insights for ear, nose and throat disorders including technology assessments, licensing opportunities, collaborations, market trends, pipeline coverage and competitive landscape. The report essentially provides DelveInsight’s proprietary market and pipeline analytics which identifies the front runners in this therapeutic area. It also identifies the potential market movers and future regulatory landscape.